InvestorsHub Logo
Followers 0
Posts 749
Boards Moderated 0
Alias Born 09/14/2017

Re: Papes post# 2140

Thursday, 06/18/2020 6:20:50 AM

Thursday, June 18, 2020 6:20:50 AM

Post# of 2794

Agreed! Very possible.



Some 2-3 years ago there was a bio-company. It bought from Germany a technology very similar to Iomab-B but it was against prostate cancer.

I don't remember any more name for this company. Maybe here is someone with better memory.

This company went to buyout for $2.1B even though there are many other treatments for prostate cancer available. I suppose demand for Iomab-B is much greater.

*******************************

Just found it. It was Novartis acquiring Endocyte.

https://www.fiercebiotech.com/biotech/novartis-inks-2-1b-endocyte-buyout-furthering-radiotherapy-push
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ATNM News